Factor Viii Formulations
A Factor VIII (FVIII) composition formulated such that NaCl is not present in the final formulation or is present in trace amounts, which allows for a concomitant reduction in the lyophilization cycle time and increased stability of the lyophilized FVIII.
Patents:WO 2,010,054,238
Inventor(s):
PIKAL MICHAEL [US]; TCHESSALOV SERGUEI [US]; BJORNSON ERIK [US]; JAMEEL FEROZ [US]; BESMAN MARC [US]
Type of Offer:
Licensing
« More Medical Patents